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Abstract: In mammalian development, primordial germ cells (PGCs) represent the initial population of cells that are com-
mitted to the germ cell lineage. PGCs segregate early in development, triggered by signals from the extra-embryonic ecto-
derm. They are distinguished from surrounding cells by their unique gene expression patterns. Some of the more common 
genes used to identify them are Blimp1, Oct3/4, Fragilis, Stella, c-Kit, Mvh, Dazl and Gcna1. These genes are involved in 
regulating their migration and differentiation, and in maintaining the pluripotency of these cells. 
Recent research has demonstrated the possibility of obtaining PGCs, and subsequently, mature germ cells from a start-
ing population of embryonic stem cells (ESCs) in culture. This phenomenon has been investigated using a variety of meth-
ods, and ESC lines of both mouse and human origin.
 Embryonic stem cells can differentiate into germ cells of both the male 
and female phenotype and in one case has resulted in the birth of live pups from the fertilization of oocytes with ESC derived 
sperm. This ﬁ  nding leads to the prospect of using ESC derived germ cells as a treatment for sterility. This review outlines 
the evolvement of germ cells from ESCs in vitro in relation to in vivo events. 
Introduction
Recent advances in stem cell research have raised the possibility of differentiating germ cells in vitro 
from a starting population of embryonic stem cells (ESCs; Hubner et al. 2003; Toyooka et al. 2003; 
Geijsen et al. 2004; Lacham-Kaplan et al. 2006; Nayernia et al. 2006). These germ cells may theoreti-
cally be used as a treatment of infertility. Preliminary studies on mice have already resulted in offspring 
being obtained from the fertilization of oocytes with in vitro derived sperm (Nayernia et al. 2006). The 
offspring, however, displayed abnormalities, resulting in premature death. In order to replicate germ 
cell development in vitro, further understanding and in depth analysis into the tissue interactions and 
molecular mechanisms involved in germ cell differentiation in vivo is necessary. 
As current research focuses on the mouse model, this review will focus on events leading to murine 
germ cell differentiation in vivo and in vitro, in relation to gene expression at speciﬁ  c embryo develop-
ment stages and gender.
Murine Germ Cell Development In Vivo
Separation of the germ line from the soma occurs early during mouse embryogenesis (Ginsburg et al. 
1990). This early separation ensures that genetic or regulatory modiﬁ  cations that occur within the 
somatic cells during development have no effect on gamete formation, and in this way, are not passed 
on to the next generation. The exact manner in which germ line segregation occurs remains unclear; 
however, numerous genes have been implicated in regulating this segregation, in addition to regulating 
the migration and differentiation of these early germ cells. 
Stages of embryology in relation to germ cell development 
Embryonic day 0.5–6.5—blastocyst formation and gastrulation 
As a result of fertilization, two haploid cells merge to form a single diploid cell known as a zygote. This 
single cell proceeds through a number of mitotic divisions known as embryonic cleavage to form a 
morula which consists of approximately 8–16 cells. Further cell division leads to the formation of a 
blastocyst which is made up of two distinct layers. The outer epithelial cell layer, known as the troph-
ectoderm, and a cluster of cells attached to one side of the inside surface of the trophectoderm, known 242
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as the inner cell mass (ICM). The remainder of the 
blastocyst is taken up by the ﬂ  uid ﬁ  lled blastocoel 
cavity (Gardner et al. 1988).
By E5.5, the embryo is made up of the inner 
epiblast and the outer visceral endoderm (Tam et al. 
1997). During the process of gastrulation, there is 
restructuring of the embryo morphology so that 
cells along the vegetal pole begin to ﬂ  atten and are 
drawn into the interior, replacing the blastocoelic 
cavity. The three germ layers, the mesoderm, endo-
derm and ectoderm, are formed during this stage 
of development. The endoderm develops into the 
digestive tract; the ectoderm, into skin and the 
central nervous system and the mesoderm develops 
into the internal organs. 
Gastrulation also involves the recruitment of 
epiblast cells to a transient embryonic structure 
called the primitive streak (Tam et al. 1993).  One 
subset of these epiblast cells move towards the 
distal part of the extraembryonic region and form 
the allantois. Another subset of these epiblast cells 
move to the apical tip in the extraembryonic meso-
derm and form the initial cluster of PGCs at E7.25 
(Lawson et al. 1994; Okamura et al. 2003).   
The manner in which PGCs are distinguished 
from the surrounding epiblast cells is unclear. Early 
experiments have suggested the existence of 
precursor PGCs within the epiblast cell population. 
These studies involved single cells being injected 
with a ﬂ  uorescent dye at E6–6.5 and its descendants 
being traced after culture (Lawson et al. 1994). 
PGCs in the embryo showed ﬂ  uorescence only 
when cells in the proximal one ﬁ  fth of the epiblast 
were injected with the dye. These results suggest 
that a precursor PGC population may exist within 
the epiblast. In contrast, others suggest that envi-
ronmental factors within the proximal region inﬂ  u-
ence the fates of the epiblast cells (Tam et al. 1996). 
Tam et al. (1996) transplanted clumps of 5–20 cells 
of the distal epiblast at E6.5 into the proximal 
region of a recipient epiblast. Grafted cells that 
normally differentiate into ectoderm behaved like 
proximal epiblast cells with some differentiating 
into PGCs, overruling the predetermination of cells 
theory in early gastrulating embryos.  
Embryonic day 7–8—primordial germ cells 
ﬁ  rst appear
Primordial germ cells are destined to give rise to 
the entire population of mature germ cells of the 
organism. They start off as a cluster of about 45 
PGCs that ﬁ  rst appear in the mouse embryo at 
E7.25 at the base of the allantois, within the poste-
rior extraembryonic mesoderm (Ginsburg et al. 
1990; Lawson et al. 1994).  
PGCs can be histologically recognized in early 
developing embryos by their large size, low nucleo-
cytoplasmic ratio, clear nuclear borders, and 
granular nuclear chromatin.  They are also identi-
ﬁ  ed by their position in the embryo, the presence 
of alkaline phosphatase activity and the presence 
of speciﬁ  c proteins that are unique to PGCs. The 
most common proteins are the transcription factor 
Oct3/4, the cell surface protein SSEA1, the nuclear 
protein Stella and the transmembrane protein 
Fragilis (Ginsburg et al. 1990; Sato et al. 2002; 
Saitou et al. 2002).
The combined action of bone morphogenetic 
protein 4 (BMP4) and BMP8b, both of which are 
expressed in the extraembryonic ectoderm 
(Yoshimizu et al. 2001), appear to be a critical 
element in PGC speciﬁ  cation (Lawson et al. 1999; 
Ying et al. 2001). Inactivation of either gene will 
result in the lack of PGCs and allantoic tissue 
(Ying et al. 2001; Chuva de Sousa et al. 2004). 
BMPs are members of the transforming growth 
factor β (TGFβ) superfamily. The receptor 
involved in BMP8b signaling in PGC segregation 
is currently unknown, however, BMP4 is thought 
to act through the type I receptor ALK3, which 
upon ligand binding is phosphorylated by the 
type II receptor TALK (ten Dijke et al. 1994; ten 
Dijke et al. 1996; Hogan, 1996; Heldin et al. 1997). 
In PGCs, BMPs mediate signaling of Smad1, 
Smad4 and Smad5 proteins (Hayashi et al. 2002; 
Tremblay et al. 2001; Chang et al. 2001), which 
in turn act to regulate the transcription of target 
genes (Miyazono et al. 2000). 
E8–13.5—Migration and proliferation 
of PGCs
PGCs begin migrating into the embryonic meso-
derm at E8.5. They continue to migrate through 
the hindgut endoderm at E9.5, along the developing 
dorsal mesentry at E10.5, until ﬁ  nally they colonize 
the gonadal ridges at E12.5 (Wylie et al. 1985). 
Whilst migrating, they also proliferate and increase 
in number from about 100 at E8.5, to 1000 at E10.5 
and to 4000 at E12.5. PGCs continue to proliferate 
after their arrival at the gonadal ridge where they 
reach about 25,000 PGCs at E13.5 (Godin et al. 
1990; Tam and Snow, 1981). PGCs appear to 243
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autonomously regulate their growth timing; in vivo 
PGCs stop proliferating at E12–13, similarly in 
vitro, PGCs will also stop proliferating at the time 
corresponding to E12–13 (Ohkubo et al. 1996).
It is hypothesized that PGC migration is 
controlled by a repulsion mechanism involving 
the proteins Fragilis and Fragilis3 (described 
further in fragilis section). Germ cells expressing 
fragilis3 are repelled from surrounding cells 
expressing fragilis. However, if both fragilis 
and fragilis3 are expressed by the germ cells, 
then the repulsion effect is inactivated (Tanaka 
et al. 2005). Thus repulsion is only exerted when 
germ cells, which originally express both 
fragilis and fragilis3, stop expressing fragilis 
but continue to express fragilis3. Furthermore, 
RNAi silencing of fragilis results in prevention 
of the migration of PGCs out of the mesoderm. 
Once in the gonadal ridge, PGCs lose their 
motile behaviour (Wylie et al. 1985).
Embryonic day 13.5–17—Differentiation to 
germ stem cells and mitotic arrest
While PGCs become established in the gonad, they 
differentiate into germ stem cells (GSCs) that 
divide by mitosis to produce the supply of gametes 
that the organism requires for reproduction. Also 
known as A spermatogonia in the male, these single 
cells either renew themselves or produce Apr 
(paired) spermatogonia predestined to differentiate 
into mature sperm (De Rooij et al. 2001). 
In the female, once mitotic proliferation stops, 
germ cells at E13.5 initiate prophase of meiosis. 
This phase is maintained until around 5 days after 
birth, where they progress to the late diplotene 
stage of the ﬁ  rst meiotic division, and again go into 
arrest. Further maturation is then continued in adult 
females with each reproductive cycle. In males, 
germ cells arrest in the G0/G1 stage of the mitotic 
cell cycle (McLaren, 1984). Meiosis is not initiated 
until after birth. 
In both males and females, meiosis is initiated 
by the expression of  the stimulated by retinoic 
acid 8 (stra8) gene, who’s expression in turn is 
stimulated by retinoic acid (Koubova et al. 2006). 
Retinoic acid is provided by the mesonephroi of 
both sexes at E13.5. However, in the testis meiosis 
is retarded by the action of a retinoid-degrading 
enzyme known as CYP26B1. In the absence of 
CYP26B1, male germ cells enter meiosis prema-
turely as in a normal ovary (Bowles et al. 2006). 
Germ cell speciﬁ  c genes and their 
role in germ cell development
PGCs are traditionally distinguished in the embryo 
by their characteristic tissue non-speciﬁ  c alkaline 
phosphatase (TNAP) staining. TNAP staining, 
however, is not speciﬁ  c to PGCs since it is also 
expressed in the surrounding somatic cells (Hustin 
et al. 1987; MacGregor et al. 1995) and is thus not 
a reliable marker of PGCs. Finding a marker purely 
speciﬁ  c to PGCs has proven difﬁ  cult, given that 
many of the genes expressed in PGCs are also 
expressed in their surrounding cells and they 
appear to be involved in maintaining or regulating 
pluripotency in PGCs. As such, these genes are 
also expressed in embryonic stem cell (ESC) and 
embryonic germ cell populations. Some of the most 
common germ cell genes used to identify PGCs 
are described in greater detail below. 
Blimp1 
Until recently the expression of Fragilis and Stella 
at E7.25 were thought to be the earliest markers 
of PGCs in the embryo. Recent studies have iden-
tiﬁ  ed an earlier marker known as B-lymphocyte-
induced maturation protein-1 (Blimp1) which is 
expressed at E6.25 in the ﬁ  rst cell layer of the 
posterior proximal epiblast. Subsequently Blimp1 
is now thought to be the earliest gene to identify 
PGCs in the embryo (Ohinata et al. 2005; Vincent 
et al. 2005). 
Blimp1 encodes a transcriptional repressor, 
originally identiﬁ  ed for its role in regulating plasma 
cell differentiation (Turner et al. 1994; Shaffer et al. 
2002; Shapiro-Shelef et al. 2003). The protein 
structure implicates it has a role in gene expression 
regulation. At the N-terminus there is a positive-
regulatory domain involved in chromatin remod-
eling, in the middle there is a proline rich region 
capable of recruiting transcriptional co-repressors 
(Ren et al. 1999; Yu et al. 2000), whilst at the 
C-terminus there are ﬁ  ve consecutive Krupple-type 
zinc ﬁ  ngers for DNA binding. In PGCs, Blimp1 
functions by forming a complex with the arginine 
methyltransferase Prmt5. This complex is believed 
to be important in germ cell speciﬁ  c epigenetic 
programming (Ancelin et al. 2006).
Blimp1 expression in the embryo is detected 
before gastrulation, at E6.25, in about four to eight 
cells located in a single layer in the most proximal 
epiblast cells (Table 1; Ohinata et al. 2005; Raz, 
2005). Considerable increases in Blimp1 expression 244
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follow, to around 16 cells at E6.5, 20–28 cells at 
E7.25, and approximately 40 Blimp1 positive cells 
at E7.5 (Ohinata et al. 2005). Expression of Blimp1 
persists in PGCs as they migrate towards the 
genital ridges (Chang and Calame, 2002). 
Results of Knock-out studies show a dose-
dependant effect of Blimp1 on PGC numbers. The 
study by Ohinata et al. (2005) observed a reduction 
in PGC number, ranging from 25 in wild-type; to 
17.5 in heterozygotes; to ﬁ  ve in Blimp1 null, E7.5 
embryos. Vincent et al. (2005) also observed a 
reduction in PGC numbers, from forty in wild-type, 
to nine in heterozygotes, and they did not detect 
any PGCs in Blimp1 mutant embryos. Both of these 
studies found that PGCs from wild-type and 
Blimp1 mutants can expand at similar rates, and 
thus both suggested Blimp1 involvement in the 
initial speciﬁ  cation of PGCs, rather than on their 
survival or proliferation (Ohinata et al. 2005; 
Vincent et al. 2005).
Oct3/4
Octamer-binding transcription factor 3/4 (Oct3/4) 
was originally identiﬁ  ed as an embryonic stem cell 
(ESC) and germline speciﬁ  c marker (Okamoto 
et al. 1990; Rosner et al. 1990; Scholer et al. 1990). 
It is currently known to be a transcription factor 
belonging to class V of the POU (Pit-Oct-Unc) 
transcription factor family (Ryan et al. 1997). 
Members of this family have in common a bipartite 
DNA binding domain containing the POU home-
odomain and the POU speciﬁ  c domain. The DNA 
sequence to which Oct3/4 binds in order to regulate 
gene expression is referred to as the octamer motif 
(Scholer et al. 1991). Upon binding of Oct3/4 to 
an octamer motif, transcription will either be initi-
ated or repressed, depending on the flanking 
sequence (Pesce et al. 2001). 
The expression of Oct3/4 is regulated by a 
proximal promoter, a germ cell speciﬁ  c distal 
enhancer and a retinoic acid responsive element. 
In the epiblast, Oct3/4 expression is driven by the 
proximal promoter. At gastrulation Oct3/4 expres-
sion is down regulated and is maintained only in 
the germ cell lineage. Oct3/4 expression is main-
tained in the germ cell lineage by the binding of 
germ cell speciﬁ  c, germ cell nuclear factor (GCNF) 
to the distal enhancer. Thus Oct3/4 expression 
continues in germ cells under the regulation of 
GCNF (Fuhrmann et al. 2001). On binding of 
retinoic acid to the retinoic acid responsive 
element, Oct3/4 expression is inhibited, allowing 
for lineage speciﬁ  c gene expression and differen-
tiation of cells. 
Oct3/4 expression is not speciﬁ  c to germ cells; 
rather it is considered a marker of pluripotency. 
Expression is seen in oocytes, the inner cell mass, 
early pre-implantation embryos, primitive ectoderm, 
PGCs, embryonic stem cells, embryonic germ cells 
and embryonic carcinoma cells (Niwa, 2001). 
Oct3/4 is also expressed at high levels in germ cell 
tumours (Looijenga et al. 2003). In the oocyte, 
Oct3/4 functions as a maternal effect gene. Both the 
maternal RNA and the maternal protein are present 
in fertilized oocytes until the two cell stage, with 
zygotic expression taking over at the four to eight 
cell stages (Scholer et al. 1990; Palmieri et al. 1994; 
Yeom et al. 1996). Oct3/4 expression decreases as 
the embryo develops, ﬁ  rst in the outer cells of the 
morula as they form the trophectoderm and then in 
Table 1. Expression patterns of PGC and GSC speciﬁ  c genes at different embryonic stages of germ cell 
development in vivo. + denotes expression at that developmental stage, − denotes no or very low expression.
Pre-
Migratory 
PGCs
Migratory 
PGCs
Post-
Migratory 
PGCs  GSCs Female GSCs Male
Embryonic 
day
6.5 7.5 8.5 9.5 10.5 11.5 12.5 13.5 14.5 15.5 16.5 17.5 13.5 14.5 15.5 16.5 17.5
Blimp1 +++++++−−−−−−−−−−
Oct3/4 +++++++++−−−+++++
Fragilis  +++++++++++++++++
Stella  −+++++++−−−−+++−−
C-Kit −+++++++−−−−++−−−
Mvh −−−−+++++++++++++
Dazl  −−−−−++++++++++++
Gcna1 −−−−+++++++++++++245
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cells of the epiblast during gastrulation (E7.5), until 
it is eventually conﬁ  ned only to the PGCs of the 
embryo (Yeom et al. 1996). 
PGCs, of both males and females, continue to 
express Oct3/4 as they proliferate and migrate to 
the genital ridges (Table 1). In the male, expression 
in the germ cells persists throughout fetal develop-
ment, and is maintained postnatally in proliferating 
gonocytes, pro-spermatogonia and in undifferenti-
ated spermatogonia (Pesce et al. 1998; Tadokoro 
et al. 2002). However, Oct3/4 expression is 
repressed in female germ cells at meiotic prophase I 
(E13–E14), and is then re-expressed after birth 
during the growth phase of the oocytes (Pesce et al. 
1998; Tadokoro et al. 2002).
The results of Oct3/4 knockout studies conﬁ  rm 
its importance in early embryogenesis, particularly 
in ICM formation. Mutant blastocysts consist only 
of trophectoderm, and die between implantation and 
egg cylinder stages (Nichols et al. 1998). As Oct3/4-
null embryos do not survive past such early devel-
opmental stages, they can not be used to examine 
the role of Oct3/4 in PGCs. However, in studies 
where Oct3/4 was ablated in PGCs during the migra-
tory stage, PGCs became apoptotic (Kehler et al. 
2004), suggesting an involvement of Oct3/4 in PGC 
survival. Studies utilizing ESCs to investigate 
Oct3/4 function found that forced over-expression 
of Oct3/4 produced primitive mesoderm and endo-
derm (Niwa et al. 2000), while down regulation 
produced trophoblast like cells (Niwa et al. 2000; 
Velkey et al. 2003; Sen et al. 2004) and intermediate 
expression maintained the pluripotency of the ESCs 
in culture (Niwa et al. 2000).
Fragilis
Fragilis is a member of the interferon-induced 
transmembrane protein gene family (Saitou et al. 
2002; Tanaka et al. 2002; Lange et al. 2003). Within 
this family are ﬁ  ve related proteins composed of 
104–144 amino acids, containing two transmem-
brane domains (Lange et al. 2003). Three of the 
members known as fragilis, fragilis2 and fragilis3, 
appear to be associated with germ cells, while the 
remaining two members, fragilis4 and fragilis5, 
are not detected within germ cells (Lange et al. 
2003). The proteins reside on the cell surface 
membrane, with the amino and carboxy terminus 
ends being located outside of the cell. 
Fragilis appears to be expressed in response to 
BMP4 signaling from the extra-embryonic 
ectoderm (Saitou et al. 2002). This is supported by 
the fact that fragilis positive cells are not detected 
in BMP4-null embryos, and are significantly 
reduced in BMP4 heterozygous embryos (Lawson 
et al. 1999). 
Fragilis expression occurs early in develop-
ment, being detected throughout the epiblast in 
E6.0 embryos (Table 1). The expression of the 
marker becomes restricted at E6.5 to a cluster of 
cells at the posterior end of the embryo. The expres-
sion of fragilis in PGCs at this time is believed to 
be important for the migration of PGCs towards 
the genital ridges. 
Stella
The Stella gene codes for a protein of 150 amino 
acids that is detected in both the nucleus and the 
cytoplasm of pre-implantation embryos in addi-
tion to the germ line (Saitou et al. 2002). The 
protein possesses a nuclear export signal, 
allowing it to shuttle between the nucleus and the 
cytoplasm. The N-terminus contains a modular 
domain which is similar to the SAP (SAF-A/B, 
Acinus and PIAS) motif; a DNA-binding domain 
that is involved in chromosomal organisation 
(Aravind et al. 2000). The C-terminus contains a 
splicing factor like motif, suggesting a role for 
Stella in RNA metabolism. In addition, the Stella 
protein is highly basic, allowing it to bind to both 
RNA and DNA (Aravind et al. 2000). In light of 
this the Stella protein is believed to be involved 
in chromosomal organisation and RNA processing 
and similar to other SAP-domain proteins, most 
likely has a role in chromosomal organisation by 
linking chromatin to RNA processes (Nayler et al. 
1998; Aravind et al. 2000; Saitou et al. 2002). 
Stella doesn’t appear to have any function in the 
cytoplasm, but its storage there ensures it remains 
inactive. This is further manifested by experi-
ments showing that forced over expression of 
Stella in somatic cells results in its containment 
within the cytoplasm (Saitou et al. 2002). 
Stella is inherited as a maternal factor and is thus 
detected in oocytes and in zygotes (Payer et al. 
2003). At the early morula stage, the maternally 
inherited Stella is degraded and replaced by the onset 
of zygotic expression (Payer et al. 2003). Stella 
expression persists until the blastocyst stage after 
which it is down regulated and doesn’t appear again 
until approximately E7.0 in 36–43 cells showing 
high Fragilis expression (Sato et al. 2002; Saitou 
et al. 2002). It continues to mark PGCs as they migrate 
through the hindgut at E8.5, and remains expressed 246
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in the germ line until about E13.5 in the female and 
E15.5 in the male (Table 1; Sato et al. 2002). Expres-
sion resumes within immature oocytes of newborn 
ovaries, and continues to be expressed in maturing 
oocytes; however no Stella expression is detected 
in adult testes. 
Although Stella appears as a speciﬁ  c germ cell 
marker during early development, it doesn’t appear 
to be directly involved in PGC emergence (Payer 
et al. 2003; Bortvin et al. 2004). Stella knockout 
studies have revealed that ﬁ  rst generation homo-
zygous mutant mice contained germ cells compa-
rable to those of wild-type or heterozygote mice. 
Spermatogenesis and ovarian follicle development 
appeared normal in these mutants and no morpho-
logical defects were detected (Bortvin et al. 2004). 
However, the second generations of mutant 
embryos die during the early cleavage stages 
(Bortvin et al. 2004), conﬁ  rming the importance 
of Stella as a maternal factor involved in pre-
implantation embryo development. 
c-Kit and stem cell factor 
C-Kit, a tyrosine kinase receptor, and its ligand 
stem cell factor (SCF; also known as Kit ligand or 
Steel factor), are key regulators of PGC growth 
and survival (De Miguel et al. 2002). Binding of 
SCF leads to dimerization of the c-Kit receptor, 
which causes the phosphorylation of different 
substrates depending on the activated pathway 
(Blume-Jensen et al. 1998). In PGCs, c-Kit is 
believed to be involved in activating the Protein 
kinase B or Akt (PKB/Akt) signaling pathway. 
However, unlike other cell types, activation of Akt 
does not appear to occur through PI3K (phospha-
tidylinositol 3-Kinase), but has been suggested to 
be activated by other c-kit downstream molecules 
such as the Sarcoma (Src) protein family (De 
Miguel et al. 2002). SCF exists as two forms, a 
membrane-bound growth factor, or as a soluble 
form resulting from proteolytic cleavage. 
C-Kit is expressed in PGCs from their initial 
segregation at E7.5 (triggered by BMP4 signaling; 
Pellegrini et al. 2003) through to their arrival at the 
genital ridge at E13.5 (Table 1). In the mouse, c-Kit 
mRNA or protein are not detected in new born 
gonocytes, but expression reappears in differenti-
ated spermatogonia and spermatocytes persisting 
until the round spermatid stage where it is no longer 
detected (Prabhu et al. 2006). Prabhu et al. (2006) 
observed that c-Kit mRNA could be detected in the 
absence of protein expression, indicating that tran-
scription and translation of c-Kit are differentially 
regulated (Prabhu et al. 2006). 
The importance of c-Kit and SCF in the germ 
cell pathway is highlighted by the ﬁ  nding that 
knock-out models are often completely sterile 
(Besmer et al. 1993; Lev et al. 1994), with 
similar effects observed in SCF mutants. Mice 
lacking membrane bound SCF are severely deﬁ  -
cient in PGCs and are sterile (Dolci et al. 1991), 
even in the presence of soluble SCF (De Miguel 
et al. 2002). 
During embryonic development, c-Kit is 
involved in the migration, proliferation, survival 
and differentiation of PGCs (Godin et al. 1991; 
Matsui, 1998; Kissel et al. 2000). SCF/Kit 
signaling is also important for the interaction 
between the SCF positive Sertoli cells and the c-Kit 
positive germ cells. Such interactions are required 
for the progression to the meiotic pachytene stage 
of spermatogenesis (Packer et al. 1995; Vincent 
et al. 1998). 
The SCF/Kit pathway involvement in cell 
survival processes has also been demonstrated in 
ESCs (Palmqvist et al. 2005), where it is believed 
to function by suppressing apoptosis through the 
pro-survival protein Bcl-2 (Bashamboo et al. 
2006). Over 80% of ESCs devoid of c-Kit signaling 
die by apoptosis when induced to differentiate 
(Bashamboo et al. 2006), which is signiﬁ  cantly 
greater then the 30% seen in wild-type ESCs 
(Duval et al. 2000). The over-expression of Bcl-2 
appears to prevent cell death of differentiating 
ESCs (Duval et al. 2004). Although the SCF/Kit 
pathway appears to be required for the survival and 
differentiation of ESCs, it is not necessary for the 
differentiation of cells of the inner cell mass from 
which ESCs are derived (Geissler et al. 1981; Horie 
et al. 1991). Thus there appears to be a common 
role for c-Kit in regulating survival and differen-
tiation of both ESCs and the germ cell lineage.
Mvh 
The mouse vasa homologue (Mvh) gene encodes 
an ATP-dependant RNA helicase of the DEAD-
box protein family (Hay et al. 1990). Mvh 
expression has not been detected in any tissue 
or embryonic cells (such as ESCs or EGCs) and 
appears to be exclusive to germ cells (Toyooka 
et al. 2000). In PGCs, Mvh expression is first 
expressed post migration, when PGCs have 247
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colonised the genital ridges, from E10.5–E12.5 
(Table 1). It appears that a germ-soma interaction 
is necessary for Mvh expression. Its expression 
continues in germ cells until the spermatogenic 
cell and maturing oocyte stages in adult mice 
(Toyooka et al. 2000). 
In the female, Mvh protein is located in the 
cytoplasm of developing oocytes. As the follicle 
matures, there is a decrease in Mvh until it is 
undetectable in mature oocytes (Toyooka et al. 
2000). In the male, Mvh appears to be closely 
associated with chromatoid bodies of spermato-
cytes and spermatids. A granulo-fibrillar 
distribution of Mvh is seen in zygotene sper-
matocytes. By the pachytene-diplotene stage, 
Mvh aggregates into several granules and forms 
one large perinuclear granule in round sperma-
tids at stage I-VII in the seminiferous tubules 
(Toyooka et al. 2000). 
Mvh-null mice produce PGCs which exhibit 
decreased proliferative activity and in males result 
in defects in spermatogenesis. Hence Mvh knock-
out studies have resulted in sterility in males, 
while homozygous females are fertile (Tanaka 
et al. 2000). 
Given that Mvh localisation coincides with the 
formation of the chromatoid body (a perinuclear 
granulo-ﬁ  brillar complex present in post meiotic 
cells, believed to function in post-transcriptional 
RNA metabolism), it is suggested that the two are 
connected (Toyooka et al. 2000).
Dazl 
Dazl, a member of the DAZ family of proteins, is 
known to bind RNA and participate in translation 
of bound RNA by the recruitment of 80S ribo-
somes (Collier et al. 2005). Speciﬁ  c to the germ 
cell lineage, Dazl is ﬁ  rst expressed in mice at 
E11.5 in post-migratory PGCs (Table 1; Seligman 
et al. 1998). In males, Dazl is situated in the cyto-
plasm of spermatogonia, pre-leptotene and zygo-
tene spermatocytes, with the highest expression 
being found in pachytene spermatocytes (Ruggiu 
et al. 1997). 
In both male and female mice, loss of Dazl 
results in the failure of germ cells to complete 
meiotic prophase (Saunders et al. 2003). Similar 
to the phenotype observed in Mvh-null male mice 
(Tanaka et al. 2000), Dazl-null male mice show 
a reduction in germ cell numbers and a failure 
of most cells to progress from Aaligned to A1 
spermatogonia (Ruggiu et al. 1997; Schrans-
Stassen et al. 2001), with few cells progressing 
to leptotene of meiotic prophase I (Saunders 
et al. 2003).
Ovaries of knock-out mice at E15 contain early 
pachytene oogonia (Ruggiu et al. 1997), however 
by E17.5 there is a large decrease in the number 
of germ cells with no more germ cells being present 
for four days after birth, resulting in infertile mice 
(Dekel, 1996; Ruggiu et al. 1997). 
Given the results of these knock-out studies, the 
fact that Dazl binds Mvh mRNA in vitro and that 
Dazl-null mice show reduced levels of Mvh 
protein, it has been suggested that one of the func-
tions of Dazl is assisting in the translation of Mvh 
in the male. It is doubtful, however, that Dazl is 
exclusive to Mvh translation as Dazl-null females 
are infertile, while Mvh-null females are fertile. 
Hence, Dazl must be involved in more than one 
process in the germ cell line.  
Gcna1
Germ cell nuclear antigen 1 (Gcna1) is a nuclear 
antigen expressed in both male and female germ 
cells (Enders et al. 1994). Gcna1 is ﬁ  rst expressed 
in post-migratory PGCs (E10.5–E11.5), once they 
have entered the genital ridge (Table 1). Gcna1 
continues to be present for the remaining embry-
onic period (Enders et al. 1994). 
In females, Gcna1 remains in oocytes until 14 
days post-partum, where it is no longer detected 
(Enders et al. 1994). In males, Gcna1 is detected 
in spermatogonia, leptotene and zygotene sper-
matocytes and spermatids. However more mature 
sperm located in the vas deferens and epididymis 
are not positive for Gcna1 expression (Enders 
et al. 1994). 
Gcna1 appears to be very speciﬁ  c to germ cells. 
It has not been detected in any somatic cells tested 
to date, however, it has been detected in embryonal 
carcinoma cells. The function and role of Gcna1 
in the germ cell lineage remains elusive. 
In Vitro Development Of Germ Cells
New advances in germ cell research have demon-
strated germ cell differentiation in in vitro systems. 
Beginning with a population of embryonic stem 
cells, germ cells were shown to either spontane-
ously arise in culture (Hubner et al. 2003) or were 
induced to differentiate down a germ cell pathway, 
by the addition of growth factors (Nayernia et al. 248
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2006) or by mimicking the early embryo environ-
ment in the form of embryoid bodies (Toyooka 
et al. 2003; Geijsen et al. 2004; Lacham-Kaplan 
et al. 2006). This in vitro system can potentially be 
used either therapeutically or as a research tool to 
enable a better understanding of germ cell differ-
entiation. Germ cell differentiation in vitro may 
provide a model for lineage commitment and early 
populations of precursor cells that are often 
extremely difﬁ  cult to access in vivo. Therapeuti-
cally, ESCs may in the future be used to cure or 
replace diseased or damaged tissue. ESCs may 
provide an unlimited source of speciﬁ  c cell types 
for transplantation, including reproductive cells. 
Embryonic stem cells
Embryonic stem cells (ESCs) originate from cells 
of the inner cell mass, collected from a developing 
blastocyst at E3.5 (Evans et al. 1981; Martin, 
1981). Once removed from the embryo, these cells 
can be maintained in culture in the presence of 
embryonic ﬁ  broblast feeder cells and/or leukemia 
inhibitory factor (LIF; Smith and Hooper, 1987; 
Smith et al. 1988; Williams et al. 1988). 
The maintenance of pluripotency and the self-
renewal properties of ESCs are a result not only of 
their environment and culture conditions, but also 
a result of their own gene expression. Transcription 
factors identiﬁ  ed to be important are the expression 
of Oct3/4 (Pesce et al. 2001), Nanog (Chambers 
et al. 2003), Sox2 (Avilion et al. 2003), and foxd3 
(Hanna et al. 2002).
Differentiation of ESCs occurs spontaneously 
upon the removal of feeder cells and LIF from the 
culture. Directing differentiation in a more 
controlled manner is most often achieved either by 
inducing formation of embryoid bodies (Boheler 
et al. 2002), adding certain growth factors to the 
cultures, nutrient restriction during ESC culture, or 
by the engineered expression of certain genes 
(Soria, 2001). Given their differentiation capabili-
ties, ESCs are often used as the starting material by 
which to obtain cells of multiple lineages in vitro. 
Germ stem cells can be obtained in vitro from 
ESCs cultured as monolayers or through the forma-
tion of embryoid bodies. Hubner et al. (2003), used 
an ESC line containing a PGC-speciﬁ  c Oct3/4-GFP 
transgene, where GFP (green ﬂ  uorescent protein) 
expression is driven by a germ cell speciﬁ  c Oct3/4 
enhancer. These cells were cultured as a monolayer, 
without feeder cells or LIF, to allow for spontaneous 
differentiation. GFP expression was ﬁ  rst evident 
after four days of culture. By day 7 of culture, 25% 
of the cells were positive for GFP as well as for 
Mvh. After 26 days of culture, cells resembling 
oocytes of 50–70 µm in diameter were present in 
the culture. These oocytes formed blastocyst like 
structures that expressed oocyte speciﬁ  c markers. 
In this study, oocyte differentiation occurred 
without additional growth factors, as cultures were 
supplemented only with serum and without any 
cellular organisation or niche formation (Hubner 
et al. 2003). 
Nayernia et al. (2006) also uses monolayers to 
obtain germ stem cells. In this study haploid male 
gametes were differentiated from ESCs after three 
weeks of retinoic acid induction. These in vitro 
derived germ cells successfully fertilized wild-type 
oocytes and resulted in the full-term development 
of embryos and live post-natal offspring. However, 
the progeny displayed abnormalities, particularly 
in methylation patterns, and died prematurely.
Embryoid bodies
Lineage speciﬁ  c differentiation can be controlled 
within embryoid bodies (EBs), derived from ESCs, 
to reﬂ  ect that found in the embryo (Keller, 2005). 
EBs provide intimate intracellular contacts that 
mimic in vivo developmental niches. Analysis of 
EBs has demonstrated the differentiation of all 
three germ layers, ectoderm, mesoderm, and endo-
derm (Leahy et al. 1999). As differentiation 
continues, there is development of a range of cell 
types including cardiomyocytes (Klug et al. 1996), 
neural precursors (Brustle et al. 1997), and haema-
topoietic precursors (Potocnik et al. 1997).  
Recent studies have demonstrated the ability of 
EBs to support the differentiation of germ cells in 
vitro. Geijsen et al. (2004) and Toyooka et al. (2003) 
obtained sperm like cells from mouse ESC derived 
EBs and Lacham-Kaplan et al. (2006) obtained 
oocyte like cells within ESC derived EBs. 
In addition to the 3D supportive structure of the 
EBs, these studies also utilized the addition of 
growth factors to direct differentiation of germ 
cells. Toyooka et al. (2003) cultured EBs in the 
presence of BMP4 producing cells to mimic the in 
vivo system of germ cell differentiation. After one 
day in the presence of BMP4, Mvh positive cells 
were obtained from the EBs. When these cells were 
transplanted to the testis of sterile mice, they gave 
rise to sperm.  249
Gene expression in germ cell differentiation
Biomarker Insights 2007: 2 
This study was soon followed by Geijsen et al. 
(2004) who cultured EBs in the presence of retinoic 
acid, which is known to rapidly differentiate ESCs 
while inducing the proliferation of PGCs. After 
around 20 days of culture, haploid male germ cells 
were obtained from the EBs. These cells gave rise 
to blastocysts when injected into oocytes. 
EBs can also support the differentiation of 
oocytes. In the study by Lacham-Kaplan et al. 
(2006), EBs were cultured in the presence of 
testicular cell conditioned (TCC) medium that was 
prepared from the testis of 1 day old newborn male 
mice. After 2 weeks of culture in TCC medium, 
the EBs resembled ovarian structures that 
contained putative oocytes. Despite that a male 
ESC line was used to form EBs and that the EBs 
were cultured in testicular cell conditioned 
medium, female germ cells were obtained. An 
interesting difference between this study, where 
female germ cells were obtained, and the study by 
Toyooka et al. (2003) and Geijsen et al. (2004), 
where male germ cells were obtained, is that male 
germ cell differentiation resulted from cells that 
were sorted and thus separated away from 
surrounding cells, and either exposed to an in vivo 
male environment (Toyooka et al. 2003) or subject 
to male germ cell differentiation stimulus such as 
retinoic acid (Geijsen et al. 2004; Nayernia et al. 
2006). Thus the isolation of cells differentiating 
down a germ cell pathway away from the other 
surrounding cells in the culture appears to be an 
important step if male germ cell differentiation is 
desired. 
Conclusions
Latest developments in ESC research have 
rendered possible the ability for the in vitro differ-
entiation of ESCs into germ cells. Hence prospects 
of using ESC derived germ cells in regenerative 
medicine to overcome infertility related to germ 
cell deﬁ  ciency are more feasible. A signiﬁ  cant 
advancement in the ﬁ  eld was the study by Nayernia 
et al. (2006) where they reported the birth of viable 
offspring from the fertilization of oocytes with in 
vitro derived sperm. Whilst this study provided a 
signiﬁ  cant breakthrough in the ﬁ  eld it also high-
lights the need for further research into this area 
given that the offspring displayed abnormalities 
resulting in premature death. 
Studies on germ cell development hold exciting 
new solutions to assisted reproduction, yet more 
questions need to be addressed. Whilst nine genes 
were described in this review, many more are 
involved in germ cell characterisation and function 
and given the complexity of these cells the chal-
lenge for researchers will be to discover the role 
of many more. Further, given the nature of exper-
iments in this ﬁ  eld and the number of in vitro 
manipulations required, it will be essential to 
explore the accuracy of these ﬁ  ndings in an in vivo 
setting, and more importantly with a functional 
read out, such as the birth of live, healthy pups with 
little or no abnormalities. In addition, a close 
investigation into the gene expression patterns 
displayed in in vitro differentiation, and whether 
this correlates with what is seen in vivo are neces-
sary. It will also be important to use proteomics to 
assist in our understanding of the interaction 
between the soma and the germ line. One of the 
major limitations that researchers currently chal-
lenge is the paucity in our understanding of the in 
vivo maturation processes of germ cells. Thus the 
challenge lies in recapitulating germ cell differen-
tiation and maturation in vitro. Collaborations 
between reproductive scientists, protein chemists 
and molecular biologists will be required if a 
complete understanding of germ cell development 
is to be obtained. 
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